Total Funding
40
6
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2783234
Abattis Bioceuticals is a biotechnology life sciences company developing health solutions for chronic illnesses in humans and animals.
Jason Anderson: CA, CFA as Vice President of Finance
Michael Bessler: Corporate Communications Consultant
About the Company
Abattis Bioceuticals Corporation is a specialty bio-technology life sciences company that has acquired intellectual property, conducts research, and works to develop proprietary health and wellness solutions that address chronic illnesses and disease in animals and humans through proprietary and patent pending formulations. The Company has
identified targeted channels to market and license proprietary patent pending products throughout the world.
http://www.abattis.com/s/news.asp?ReportID=692690
SEDAR Filings:
http://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00011477
